- Home
- GOSS vs AKA Comparison
GOSS vs AKA Comparison
Compare GOSS & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | AKA |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.8M | 137.0M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GOSS | AKA |
|---|---|---|
| Price | $3.62 | $11.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $8.60 | ★ $25.75 |
| AVG Volume (30 Days) | ★ 3.0M | 7.8K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $44,051,000.00 | ★ $595,281,000.00 |
| Revenue This Year | N/A | $5.57 |
| Revenue Next Year | $6.41 | $4.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.44 |
| 52 Week Low | $0.76 | $7.00 |
| 52 Week High | $3.80 | $21.90 |
Technical Indicators
Market Signals| Indicator | GOSS | AKA |
|---|---|---|
| Relative Strength Index (RSI) | 69.66 | 45.45 |
| Support Level | $3.34 | $10.63 |
| Resistance Level | $3.80 | $12.00 |
| Average True Range (ATR) | 0.20 | 0.82 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 83.64 | 29.99 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.